“Appropriate utilization of the prognostic 40-gene expression profile (40-GEP) test for cutaneous squamous cell carcinoma (cSCC) demonstrated by clinical reports and physician evaluation of real-world cases”, J of Skin, vol. 6, no. 2, p. s21, Mar. 2022, doi: 10.25251/skin.6.supp.21.